Literature DB >> 16099238

Tissue responses to thyroid hormone in a kindred with resistance to thyroid hormone harboring a commonly occurring mutation in the thyroid hormone receptor beta gene (P453T).

Sharon Y Wu1, Peter M Sadow, Samuel Refetoff, Roy E Weiss.   

Abstract

Resistance to thyroid hormone (RTH) is a dominantly inherited syndrome of reduced tissue responsiveness to thyroid hormone (TH) usually due to mutations in the TH receptor beta gene (TRbeta). We studied pituitary and peripheral tissue responses to graded doses of liothyronine (L-T3) in 5 affected members (2 children and 3 adults) of a family with RTH due to the common TRbeta mutation P453T. Overall, the 5 subjects studied exhibited suppressed thyrotropin response to thyrotropin-releasing hormone of 51% +/- 8%, 12.1% +/- 1.5%, and 6.3% +/- 3% of the 100% baseline on 50, 100, and 200 microg/dL L-T3, respectively. This degree of suppression was greater than that observed in subjects with RTH due to other TRbeta mutations, indicating less resistance. Compared with normal subjects, however, the family described here demonstrated less suppression by L-T3, compatible with their RTH, although of a mild magnitude. The 2 children with RTH demonstrated less L-T3-mediated suppression of prolactin and cholesterol than the adults. Patients often receive thyroid ablative therapy before the diagnosis of RTH and are left with variable degrees of hypothyroidism. Our results demonstrate that graded doses of L-T3 can be used to evaluate RTH patients, even under the condition of limited thyroid reserve, when results are compared with their baseline. We demonstrate that RTH patients can be evaluated either on or off thyroid hormone and still be distinguished from hypothyroid subjects without RTH.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16099238     DOI: 10.1016/j.lab.2005.04.005

Source DB:  PubMed          Journal:  J Lab Clin Med        ISSN: 0022-2143


  8 in total

1.  Pathogenic mechanism of mutations in the thyroid hormone receptor β gene.

Authors:  S Pongjantarasatian; S Wacharasindhu; S Tongkobpetch; K Suphapeetiporn; V Shotelersuk
Journal:  J Endocrinol Invest       Date:  2011-07-27       Impact factor: 4.256

2.  A Patient With a Thyrotropin-Secreting Microadenoma and Resistance to Thyroid Hormone (P453T).

Authors:  Xiaochun Teng; Ting Jin; Gregory A Brent; Anhua Wu; Weiping Teng; Zhongyan Shan
Journal:  J Clin Endocrinol Metab       Date:  2015-04-13       Impact factor: 5.958

3.  Thyroid hormone receptor beta and NCOA4 regulate terminal erythrocyte differentiation.

Authors:  Xiaofei Gao; Hsiang-Ying Lee; Wenbo Li; Randall Jeffrey Platt; M Inmaculada Barrasa; Qi Ma; Russell R Elmes; Michael G Rosenfeld; Harvey F Lodish
Journal:  Proc Natl Acad Sci U S A       Date:  2017-09-01       Impact factor: 11.205

4.  Thyroid hormone receptor beta gene mutation (P453A) in a family producing resistance to thyroid hormone.

Authors:  T Bayraktaroglu; J Noel; F Alagol; N Colak; N M Mukaddes; S Refetoff
Journal:  Exp Clin Endocrinol Diabetes       Date:  2008-06-17       Impact factor: 2.949

Review 5.  Thyrotropin-secreting pituitary adenomas: epidemiology, diagnosis, and management.

Authors:  Fatemeh G Amlashi; Nicholas A Tritos
Journal:  Endocrine       Date:  2016-01-21       Impact factor: 3.633

6.  Identification of a novel mutation in the thyroid hormone receptor β gene that causes thyroid hormone resistance syndrome: A case report.

Authors:  Jue Wang; Haihong Lv
Journal:  Mol Med Rep       Date:  2019-09-24       Impact factor: 2.952

Review 7.  Role of Nuclear Receptors in Controlling Erythropoiesis.

Authors:  Valentina Pastori; Serena Pozzi; Agata Labedz; Sajeela Ahmed; Antonella Ellena Ronchi
Journal:  Int J Mol Sci       Date:  2022-03-03       Impact factor: 5.923

Review 8.  Update on resistance to thyroid hormone syndromeβ.

Authors:  Hongping Sun; Lin Cao; Rendong Zheng; Shaofeng Xie; Chao Liu
Journal:  Ital J Pediatr       Date:  2020-11-11       Impact factor: 2.638

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.